Yahoo
Nasdaq - Delayed Quote USD

Emerald Growth C (HSPCX)

12.05 +0.21 (+1.77%)
At close: 4:56:07 PM EDT
Chart Range Bar
Loading chart for HSPCX
  • Previous Close 11.84
  • YTD Return 21.15%
  • Expense Ratio 1.76%
  • Category Small Growth
  • Last Cap Gain 21.00
  • Morningstar Rating
  • Morningstar Risk Rating --
  • Net Assets 1.44B
  • Beta (5Y Monthly) 1.58
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 45.00%
  • Last Dividend 0.57
  • Inception Date Jul 3, 2000

Under normal conditions, invest at least 80% of the value of its assets in equity securities of U.S. and foreign companies, principally common stocks and preferred stocks, identified by the Adviser as having growth characteristics. It can invest in companies from a wide range of industries and of various sizes. This includes smaller companies, which are defined by the Adviser as those having a market capitalization equal to or less than that of the largest companies in the Russell 2000 Index.

Emerald

Fund Family

Small Growth

Fund Category

1.44B

Net Assets

2000-07-03

Inception Date

Performance Overview

View More

Trailing returns as of 9/29/2026. Category is Small Growth.

YTD Return

HSPCX
21.15%
Category
12.40%

1-Year Return

HSPCX
36.99%
Category
55.69%

3-Year Return

HSPCX
26.06%
Category
19.34%

5-Year Return

HSPCX
9.63%
Category
20.72%

People Also Watch

Holdings

View More

Top 10 Holdings (20.85% of Total Assets)

Symbol Company % Assets
F/m Emerald Life Sciences Innovation ETF 6.13%
AAR Corp. 1.95%
InterDigital, Inc. 1.83%
Travere Therapeutics, Inc. 1.68%
VSE Corporation 1.68%
Mercury Systems, Inc. 1.63%
Corcept Therapeutics Incorporated 1.54%
ESCO Technologies Inc. 1.51%
Sensient Technologies Corporation 1.47%
Guardant Health, Inc. 1.44%

Sector Weightings

Top Mutual Funds

Mobilize your Website
View Site in Mobile | Classic
Share by: